Navigation Links
Satori Pharmaceuticals Adds Key Senior Members to its Leadership Team
Date:4/26/2010

CAMBRIDGE, Mass., April 26 /PRNewswire/ -- Satori Pharmaceuticals Incorporated, a privately held developer of therapeutics for Alzheimer's disease, today announced the election of Steven Holtzman to Chair of its Board of Directors and the appointment of Jeff Jonker as its Chief Business Officer.

Steven Holtzman, the Executive Chair and co-founder of Infinity Pharmaceuticals, recently joined the Satori Board of Directors and has now agreed to assume the role of Chair.  Steve will work closely with Satori CEO Jeff Ives and Satori's management team to continue to build a leading Alzheimer's drug discovery company.

Jeff Jonker has recently joined Satori as its CBO to further strengthen the leadership of Satori and provide expertise in developing and executing on Satori's corporate strategy.  Jeff will be responsible for managing the Company's business functions, including corporate and business development.

"We are excited to have Jeff join as another important addition to our team," said Dr. Ives.  "Jeff has an impressive record of building successful companies and establishing strong collaborations.  Strategic partners will be significant to us as we continue to grow Satori into a leading Alzheimer's disease drug di
'/>"/>

SOURCE Satori Pharmaceuticals Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... , October 17, 2014 Investor-Edge ... Inc. (NASDAQ: ARNA ), NPS Pharmaceuticals Inc. ... XOMA ), Momenta Pharmaceuticals Inc. (NASDAQ: ... Free research on these five companies can be accessed ... on Thursday, October 16, 2014, ended on a mixed ...
(Date:10/17/2014)... Wash. , Oct. 17, 2014  Talyst, a ... the 2014 LeadingAge Annual Meeting in Nashville, ... InSite System, the market leading solution for onsite, remote ... long term care facilities to safely and securely dispense ... time to first dose, helps ensure that the correct ...
(Date:10/17/2014)... , Oct. 17, 2014   InnFocus, Inc ., reported ... the United States for up to 3 years ... Summit in Chicago . The ... of the annual meeting of the American Academy of ... treated approximately 150 glaucoma patients in 6 countries by early ...
Breaking Medicine Technology:Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 2Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 4Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 5Talyst Exhibits at LeadingAge Annual Meeting 2InnFocus Featured at the Ophthalmology Innovation Summit In Chicago 2
... PHILADELPHIA and LONDON , June 28 ... portfolio of drugs, whilst the proportion of total sales from newer drugs ... Factbook complied by CMR International, a Thomson Reuters business. , ... The new edition of the R&D Factbook ...
... Fla. , June 26 Data ... that linagliptin achieved statistically significant and sustained reductions ... (HbA1c),(1-4) fasting plasma glucose (FPG)(1-4) and postprandial glucose ... dipeptidyl peptidase 4 (DPP-4) inhibitor as an oral ...
Cached Medicine Technology:Global Pharmaceutical R&D Productivity Declining According to Thomson Reuters, CMR International 2Global Pharmaceutical R&D Productivity Declining According to Thomson Reuters, CMR International 3Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes 2Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes 3Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes 4Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes 5Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes 6Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes 7Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes 8
(Date:10/19/2014)... been working in the garment industry for decades, LunaDress’ dress ... James, one of the company’s top designers, many ladies like ... that add beauty to them. Chiffon floor length outfits are ... new selection of 2014 long prom dresses. , As ... available in over 20 popular designs. The company intends to ...
(Date:10/19/2014)... 20, 2014 Recently, Fancyflyingfox.com, an innovative ... clothes, has announced its latest designs of 2014 ... the new elegant outfits are offered with big discounts, ... order before October 30 can enjoy this special offer. ... marketing strategies, it has become one of the leading ...
(Date:10/19/2014)... NC (PRWEB) October 19, 2014 ... building program has just been released to the ... the online body building and fitness community. The ... attention of DietsAndFitnessGuides.com's Vin Delmonico prompting an investigative ... experience of hitting what is commonly known as ...
(Date:10/19/2014)... Oct. 19, 2014 (HealthDay News) -- New stem cell-based ... lead to new treatments, a new study suggests. ... human intestinal tissue in a lab dish. They then ... for studying intestinal disorders, according to the researchers. ... diseases and conditions that can cause intestinal failure, from ...
(Date:10/19/2014)... – The U.S. Government has initiated a major ... by 2025. However, a workgroup of nearly 40 ... in the U.S. Government,s National Plan to Address ... in scale, and adequately funded in order to ... by the workgroup to enlarge and strengthen the ...
Breaking Medicine News(10 mins):Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2Health News:Visual Impact Frequency Training Review: Rusty Moore's Latest Fitness Guide Released 2Health News:Scientists Grow, Implant Human Intestinal Tissue in Mice 2Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 2Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 3Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 4Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 5Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 6
... published insight into the biology of many kinds of less-aggressive ... wide array of possibilities for new therapies, according to scientists ... (UCSF). In paper published online Dec. 15 in the ... a genetic mutation leads to an abnormal metabolic process in ...
... happy holiday thought, but an important one: The number of ... surges by 33 percent on New Year,s Day. The suspected ... by sociologist David Phillips of the University of California, San ... on New Year,s is published in the journal Addiction ...
... Reporter , WEDNESDAY, Dec. 15 (HealthDay News) -- In a rare ... AIDS no longer has any detectable HIV cells in his blood ... But experts were quick to caution that the case ... As it turns out, the donor for that transplant ...
... HealthDay Reporter , WEDNESDAY, Dec. 15 (HealthDay News) -- Making ... diagnosis is not only unnecessary but may make it less likely ... a new study finds. Researchers reviewed records from the New ... who had been declared brain dead. All of the people had ...
... ICELAND, 15 December 2010 Scientists from deCODE genetics ... Spain and Romania today report the discovery of a ... human genome (SNPs) that impact individual baseline levels of ... is the most commonly used screening tool for the ...
... The recently identified TRIM24 protein plays an active role ... and, potentially, into breast cancer. Reporting in the ... at The University of Texas MD Anderson Cancer Center ... toward active expression. This expression, in turn, sets the ...
Cached Medicine News:Health News:Insight offers new angle of attack on variety of brain tumors 2Health News:Insight offers new angle of attack on variety of brain tumors 3Health News:SIDS spikes on New Year's Day 2Health News:Docs Claim Transplant Cured Man of HIV, But Experts Urge Caution 2Health News:Docs Claim Transplant Cured Man of HIV, But Experts Urge Caution 3Health News:Second Brain Death Exam Unnecessary, Study Finds 2Health News:Second Brain Death Exam Unnecessary, Study Finds 3Health News:deCODE discovers genetic markers that improve the power of PSA testing for detecting prostate cancer 2Health News:Protein disables p53, drives breast cells toward cancer transition 2Health News:Protein disables p53, drives breast cells toward cancer transition 3
Anti-PR3 EIA Auto-Immune Markers 013-PR3-96 Proteinase...
... For the quantitative determination of ... ,Patients with atopic allergic diseases such ... fever have been shown to exhibit ... blood. IgE is also known as ...
... growth factor 1 (IGF-1) is a polypeptide of ... of a number of related insulin-like growth factors ... 50% sequence homology with proinsulin and has a ... peptide is growth hormone (GH) dependent to a ...
...
Medicine Products: